Literature DB >> 12223477

Protein kinase C(mu) regulation of the JNK pathway is triggered via phosphoinositide-dependent kinase 1 and protein kinase C(epsilon).

Ilona Brändlin1, Tim Eiseler, Rüdiger Salowsky, Franz-Josef Johannes.   

Abstract

The protein kinase C (PKC)-related enzyme PKC(mu)/PKD (protein kinase D) is activated by activation loop phosphorylation through PKC(eta). Here we demonstrate that PKC(mu) is activated by the direct phosphorylation of PKC(epsilon). PKC(mu) colocalizes with PKC(epsilon) in HEK293 and MCF7 cells as shown by confocal immunofluorescence analyses. PDK1, known as the upstream kinase for several PKC isozymes, associates intracellularly with PKC(epsilon) and PKC(eta). PKC(eta) is phosphorylated by PDK1 in vitro, leading to kinase activation as similarly reported for PKC(epsilon) activation by PDK1. Coexpression of PDK1, PKC(epsilon) and PKC(mu) in HEK293 cells results in PKC(mu) activation. In contrast, the coexpression of PDK1 and PKC(eta) with PKC(mu) does not activate PKC(eta) or consequently PKC(mu). PDK1/PKC(epsilon)-triggered activation of PKC(mu) inhibits JNK, a downstream effector of PKC(mu), whereas upon transient expression of PDK1, PKC(eta), and PKC(mu), JNK is not affected. These data implicate PKC(epsilon) as the biologically important upstream kinase for PKC(mu) in HEK293 cells, regulating downstream effectors. Our results further indicate a PDK1/PKC(eta)/PKC(mu) controlled negative regulation of PKC(eta) kinase activity. In this study, we show that differentially activated kinase cascades involving PDK1 and novel PKC isotypes are responsible for the regulation of PKC(mu) activity and consequently inhibit the JNK pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223477     DOI: 10.1074/jbc.M205299200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Protein kinase Cδ mediates the activation of protein kinase D2 in platelets.

Authors:  Dheeraj Bhavanasi; Soochong Kim; Lawrence E Goldfinger; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

2.  Inhibition of TROY promotes OPC differentiation and increases therapeutic efficacy of OPC graft for spinal cord injury.

Authors:  Liang Sun; Shengliang Liu; Qi Sun; Zhuying Li; Fengyan Xu; Chunmei Hou; Toshihide Harada; Ming Chu; Kun Xu; Xiaoling Feng; Yongshun Duan; Yafang Zhang; Shuliang Wu
Journal:  Stem Cells Dev       Date:  2014-06-16       Impact factor: 3.272

Review 3.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

4.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

Review 5.  The substrates and binding partners of protein kinase Cepsilon.

Authors:  Philip M Newton; Robert O Messing
Journal:  Biochem J       Date:  2010-03-29       Impact factor: 3.857

6.  RhoA protects the mouse heart against ischemia/reperfusion injury.

Authors:  Sunny Yang Xiang; Davy Vanhoutte; Dominic P Del Re; Nicole H Purcell; Haiyun Ling; Indroneal Banerjee; Julie Bossuyt; Richard A Lang; Yi Zheng; Scot J Matkovich; Shigeki Miyamoto; Jeffery D Molkentin; Gerald W Dorn; Joan Heller Brown
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

7.  Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.

Authors:  Kristina Jonsson-Schmunk; Piynauch Wonganan; Jin Huk Choi; Shellie M Callahan; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2016-02-11       Impact factor: 3.922

Review 8.  Revisited and revised: is RhoA always a villain in cardiac pathophysiology?

Authors:  Shigeki Miyamoto; Dominic P Del Re; Sunny Y Xiang; Xia Zhao; Geir Florholmen; Joan Heller Brown
Journal:  J Cardiovasc Transl Res       Date:  2010-05-27       Impact factor: 4.132

9.  Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.

Authors:  Mariana M Belcheva; Amy L Clark; Paul D Haas; Jannie S Serna; Jason W Hahn; Alexi Kiss; Carmine J Coscia
Journal:  J Biol Chem       Date:  2005-06-08       Impact factor: 5.157

10.  Protein kinase D isoforms are expressed in rat and mouse primary sensory neurons and are activated by agonists of protease-activated receptor 2.

Authors:  Silvia Amadesi; Andrew D Grant; Graeme S Cottrell; Natalya Vaksman; Daniel P Poole; Enrique Rozengurt; Nigel W Bunnett
Journal:  J Comp Neurol       Date:  2009-09-10       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.